About this trial

In this study, the investigators will follow two small cohorts of pregnant women: a cohort of healthy women with uncomplicated pregnancies residing at high altitude, a control group of healthy women with uncomplicated pregnancies residing at sea level, to characterize differences in cardiopulmonary adaptation and nitric oxide (NO) pathway expression at elevations \>3,500 m throughout pregnancy and into the postpartum period. The investigators aim to investigate right-sided cardiac impairment induced by chronic hypobaric hypoxemia, its effects on fetal growth, and the potential contribution of cardiovascular nitric oxide depletion to obstetric complications.

Eligibility criteria

Qualifiers

women delivering at participating hospitals at more than 3500 meters or women delivering at participating hospitals at sea level

signed informed consent

Disqualifiers

preexisting cardiopulmonary pathologies (CHD, COPD, CKD, NYHA > III)

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

27 Participants
are grouped into 2 trial groups

Locations

2
Bolivia
Hospital De La Meujer La Paz Bolivia
United States
Massachusetts General Hospital02114, BostonMassachusetts, United States

Sponsors and collaborators

Massachusetts General Hospital

Lead sponsor